Idun Pharmaceuticals Overview
- Year Founded
-
1993
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Idun Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company intended to discover and develop drug candidates to control apoptosis.
Contact Information
Corporate Office
- 12463 Rancho Bernardo Road
- Suite 554
- San Diego, CA 92121
- United States
Corporate Office
- 12463 Rancho Bernardo Road
- Suite 554
- San Diego, CA 92121
- United States
Idun Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Out of Business | 29-Dec-2017 | 00.00 | Completed | Out of Business | ||
| 9. Secondary Transaction - Private | 00.00 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 00.00 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 10-Jul-2015 | 00.000 | 00.00 | Completed | Generating Revenue | |
| 6. Later Stage VC | 26-Jan-2015 | 00.00 | 00.000 | Completed | Generating Revenue | |
| 5. Later Stage VC | 06-Oct-2014 | 00000 | 00000 | Completed | Generating Revenue | |
| 4. Merger/Acquisition | 30-Jul-2010 | Completed | Generating Revenue | |||
| 3. Merger/Acquisition | 24-Feb-2005 | 000.00 | Completed | Clinical Trials - General | ||
| 2. Later Stage VC (Series B1) | 14-Jun-2004 | $38.6M | $61.5M | 00000 | Completed | Clinical Trials - General |
| 1. Later Stage VC (Series A1) | 09-Dec-2002 | $22.9M | $22.9M | Completed | Clinical Trials - General |
Idun Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Idun Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Idun Pharmaceuticals Patents
Idun Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20100190688-A1 | Tetrapeptide analogs | Inactive | 12-Jul-2004 | 0000000000 | 0 |
| AU-2005271831-A1 | Tetrapeptide analogs | Inactive | 12-Jul-2004 | 0000000000 | |
| EP-2457895-A1 | Tetrapeptide analogs | Inactive | 12-Jul-2004 | 0000000000 | 00 |
| EP-2457896-A1 | Tripeptides as caspase modulators | Inactive | 12-Jul-2004 | 0000000000 | 00 |
| JP-2011102312-A | Tetrapeptide analog | Pending | 12-Jul-2004 | C07D207/16 | 0 |
Idun Pharmaceuticals FAQs
-
When was Idun Pharmaceuticals founded?
Idun Pharmaceuticals was founded in 1993.
-
Who is the founder of Idun Pharmaceuticals?
Horvit Robert Ph.D, John Reed, Lawrence Bock, and Lawrence Fritz Ph.D are the founders of Idun Pharmaceuticals.
-
Where is Idun Pharmaceuticals headquartered?
Idun Pharmaceuticals is headquartered in San Diego, CA.
-
What industry is Idun Pharmaceuticals in?
Idun Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Idun Pharmaceuticals a private or public company?
Idun Pharmaceuticals is a Private company.
-
What is Idun Pharmaceuticals’s current revenue?
The current revenue for Idun Pharmaceuticals is 000000.
-
How much funding has Idun Pharmaceuticals raised over time?
Idun Pharmaceuticals has raised $3.1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
